There are small differences between the four agents and your doctor will take these into consideration when considering the best one for you.
Bleeding in the gut occurs in 8-30:1000 per year. The trials have shown that bleeding in the brain is much less common with these agents: 1-5:1000 per year. Bleeding in the gut occurs in about 10-20:1000 people every year The risk of this happening in the brain is about 5-7:1000 people taking the medication for a year. The commonest side effect is the risk of bleeding, either in the brain or from the gut. These medications are as effective as warfarin in reducing the risk of stroke. Warfarin reduces the risk of stroke from 40:1000 people to 14:1000 people. The table below may help you choose between the options available and details the risks and benefits of Warfarin and DOACs.īenefits in terms of reducing the risk of stroke Your doctor has decided that you need strong blood thinning medication to reduce your risk of stroke from atrial fibrillation (a heart rhythm problem) or to treat a clot in your legs or lungs. The first two come as a twice a day dose, and the last two as a once a day dose. There are four different DOACs: Dabigatran, Apixaban, Edoxaba and Rivoroxaban. The second option is a group of medications that are collectively known as direct oral anticoagulants (DOACs). What is the name of the proposed treatment? The decision tool below is designed to clarify for you the relative advantages and disadvantages of the different groups of medications, which in turn should help you to choose between the two groups. There are a few different medications available. Your doctor has decided that you would need a strong blood thinning medication to reduce your risk of stroke from atrial fibrillation (a heart rhythm problem) or to treat a clot in your legs or lungs. Need some help choosing a language? Please refer to Browsealoud Supported Voices and Languages. You can translate this page by using the headphones button (bottom left) and then select the globe to change the language of the page.
0 kommentar(er)
